Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Immunovant, Inc. (IMVT)

29.17 -0.47 (-1.59%)
At close: October 30 at 4:00:01 PM EDT
29.17 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade IMVT on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
0
0
0
0
0
Operating Expense
566,001
532,902
438,152
270,209
208,276
Operating Income
-566,001
-532,902
-438,152
-270,209
-208,276
Net Non Operating Interest Income Expense
26,088
25,330
24,732
24,948
7,578
Other Income Expense
998
2,181
471
-13,508
-10,253
Pretax Income
-538,915
-505,391
-412,949
-258,769
-210,951
Tax Provision
-698
215
891
567
9
Net Income Common Stockholders
-538,217
-505,606
-413,840
-259,336
-210,960
Diluted NI Available to Com Stockholders
-538,217
-505,606
-413,840
-259,336
-210,960
Basic EPS
-2.81
-2.77
-2.73
-1.88
-1.71
Diluted EPS
-2.81
-2.77
-2.73
-1.88
-1.71
Basic Average Shares
191,089.33
182,421.23
151,573.55
138,100.58
123,075.33
Diluted Average Shares
191,089.33
182,421.23
151,573.55
138,100.58
123,075.33
Total Expenses
566,001
532,902
438,152
270,209
208,276
Net Income from Continuing & Discontinued Operation
-538,217
-505,606
-413,840
-259,336
-210,960
Normalized Income
-538,217
-505,606
-413,840
-249,461
-200,960
Interest Income
26,088
25,330
24,732
24,948
7,578
Net Interest Income
26,088
25,330
24,732
24,948
7,578
EBIT
-566,001
-532,902
-438,152
-270,209
-208,276
EBITDA
-565,607
-532,493
-437,775
-269,978
-208,083
Reconciled Depreciation
394
409
377
231
193
Net Income from Continuing Operation Net Minority Interest
-538,217
-505,606
-413,840
-259,336
-210,960
Total Unusual Items Excluding Goodwill
0
0
0
-12,500
-10,000
Total Unusual Items
0
0
0
-12,500
-10,000
Normalized EBITDA
-565,607
-532,493
-437,775
-257,478
-198,083
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-2,625
0
3/31/2023 - 6/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: